Calluna Pharma launches and announces EUR 75 million Series A financing to develop novel therapies for inflammatory and fibrotic diseases

Oxitope Pharma (Oxitope) and Arxx Therapeutics (Arxx), companies with a shared goal of leveraging the innate immune system to discover and develop disease modulating therapies, today announced their merger to form Calluna Pharma Inc. (Calluna).

Roivant makes another deal, selling Dermavant to Organon for up to $1.2B

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 19, 2024

PerfectServe, TeamBuilder Partner to Bring Provider & Staff Scheduling to Medical Groups

What You Should Know: – PerfectServe®, a leader in cloud-based clinical collaboration and provider scheduling, and TeamBuilder, a provider of innovative workforce management solutions, announced

April 12, 2024

Adults with PTSD have smaller cerebellums, study reveals

Adults with posttraumatic stress disorder (PTSD) have smaller cerebellums, according to new research from a Duke-led brain imaging study.

January 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.